New insights into therapy with monoclonal antibodies in allograft transplantation.
作者信息
Schena F P
机构信息
Institute of Nephrology, University of Bari, Polyclinic, Italy.
出版信息
Nephrol Dial Transplant. 1997;12 Suppl 1:55-8.
PMID:9075230
Abstract
摘要
相似文献
1
New insights into therapy with monoclonal antibodies in allograft transplantation.
Nephrol Dial Transplant. 1997;12 Suppl 1:55-8.
2
Review and preview of anti-T-cell antibodies.
Transplant Proc. 1995 Oct;27(5 Suppl 1):8-9.
3
Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejection.
Transplant Proc. 1993 Feb;25(1 Pt 1):820-2.
4
Refractory acute kidney transplant rejection with CD20 graft infiltrates and successful therapy with rituximab.
Clin Transplant. 2005 Feb;19(1):137-40. doi: 10.1111/j.1399-0012.2004.00292.x.
5
Monoclonal antibodies in organ transplantation.
Transplant Proc. 1996 Dec;28(6):3293.
6
The clinical application of monoclonal antibody therapies in renal transplantation.
Expert Opin Emerg Drugs. 2004 May;9(1):23-37. doi: 10.1517/eoed.9.1.23.32957.
7
CD4 monoclonal antibodies in the preclinical dog renal allograft model.
Transplant Proc. 1993 Feb;25(1 Pt 1):804-6.
8
Case 6: benefits and risks of OKT3 treatment in renal transplantation.
Transplantation. 2001 Sep 27;72(6):1177-8.
9
OKT3 treatment of steroid- and/or anti-thymocyte globulin-resistant renal allograft rejection occurring on triple baseline immunosuppression including cyclosporine A.
Transplant Proc. 1988 Oct;20(5 Suppl 6):90-5.
10
Selection criteria for antirejection therapy.
Transplant Proc. 1990 Dec;22(6):2601-3; discussion 2603-4.
引用本文的文献
1
Therapeutic drug monitoring of immunosuppressant drugs.
Br J Clin Pharmacol. 1999 Apr;47(4):339-50. doi: 10.1046/j.1365-2125.1999.00911.x.
Zotero 插件